Oral Glucose Tolerance Test (OGTT)
The oral glucose tolerance test (OGTT) is a functional test assessing how the body handles a standardized dose of glucose over time — from a fasting measurement, through drinking a 75 g glucose solution, to serial blood draws over the following hours. Unlike a single fasting glucose measurement or HbA1c, it reveals early, dynamic disturbances in glucose tolerance.
Number of studies
2
Safety
Requires caution
Time to effects
Not applicable — the OGTT is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
The oral glucose tolerance test (OGTT) is a functional test assessing how the body handles a standardized dose of glucose over time — from a fasting measurement, through drinking a 75 g glucose solution, to serial blood draws over the following hours. Unlike a single fasting glucose measurement or HbA1c, it reveals early, dynamic disturbances in glucose tolerance.
- →Detects early carbohydrate metabolism disturbances that are missed when assessing fasting glucose alone
- →Gold standard for diagnosing gestational diabetes within an established window of pregnancy
- →Provides a dynamic picture of the body's response to a carbohydrate load, not just a single measurement point
| Test type | Functional blood test assessing the dynamic glycemic response to a 75 g glucose load |
|---|---|
| Level of evidence | Strong — one of three officially recognized criteria for diagnosing diabetes per WHO/ADA |
| Target group | People with borderline fasting glucose, pregnant women (weeks 24–28), people at risk of type 2 diabetes |
| Key parameters | Fasting glucose and glucose at 1 and 2 hours after drinking the glucose solution (mg/dl or mmol/l) |
| Preparation | 8–12 hours fasting, normal carbohydrate diet for at least 3 days before the test, rest during the test |
| Status | Blood test performed at diagnostic facilities, requiring attendance for about 2–2.5 hours |
Understand
Overview
The oral glucose tolerance test (OGTT) is a functional test that assesses the body's dynamic ability to metabolize glucose after a standardized carbohydrate load. Unlike a single glucose measurement, which provides only a snapshot of blood glucose concentration at a given moment, the OGTT records the body's full response curve over time — from a baseline fasting value, through a peak after glucose consumption, to a return to values close to baseline after two hours in a healthy person.
The clinical value of this test lies in the fact that it captures disturbances in carbohydrate metabolism much earlier than fasting glucose alone. In many people developing insulin resistance and prediabetes, fasting glucose remains within the normal range for a long time, because the liver and pancreas compensate for growing tissue resistance to insulin, while the ability to effectively clear a large, single dose of glucose from the blood deteriorates much earlier — and it's precisely this that the OGTT reveals. The test is also, alongside fasting glucose and HbA1c, one of three officially recognized criteria for diagnosing diabetes, and the only one allowing diagnosis of an intermediate state — impaired glucose tolerance — that's invisible on the other two tests.
The OGTT is ordered in several distinct clinical contexts. The most common is clarifying a diagnosis in people with borderline fasting glucose or an ambiguous HbA1c result, in whom the clinical picture (abdominal obesity, family history of diabetes, polycystic ovary syndrome) suggests carbohydrate metabolism disturbances despite normal results on routine tests. A second, very common indication is screening for gestational diabetes, performed routinely between weeks 24 and 28 of pregnancy in almost all pregnant women, given the distinct physiology of carbohydrate metabolism in pregnancy and the consequences of undetected hyperglycemia for the course of pregnancy and the child's health. A third group consists of people being diagnosed for reactive postprandial hypoglycemia or, in an extended protocol with simultaneous insulin measurement, for insulin resistance.
On the practical side, the test requires careful preparation. The patient should fast for 8–12 hours before the test, and for at least three days before the test should eat a normal diet containing at least 150 g of carbohydrates daily — too low a carbohydrate intake before the test can artificially worsen the result, mimicking a glucose intolerance that doesn't actually exist. On the day of the test, blood is drawn while fasting, then the patient drinks, within a maximum of 5 minutes, a solution containing 75 g of anhydrous glucose dissolved in water, after which they rest (no walking, eating, or smoking) for the next two hours, during which blood is drawn after one hour and after two hours from drinking the solution. The whole test therefore usually takes two to two and a half hours, and the result is typically available within one business day.
Several recurring misunderstandings surround the OGTT. Some patients assume the test measures exactly the same thing as HbA1c — in reality, HbA1c reflects average glucose over roughly the past three months, while the OGTT assesses the body's dynamic, current response to a specific carbohydrate load, which makes the two tests complementary rather than interchangeable. Another common misconception is treating fasting glucose alone as sufficient — in many people it's precisely the result at the 120-minute mark of the test, not the baseline glucose, that reveals impaired glucose tolerance.
The test protocol differs somewhat depending on the patient group and the purpose of the test. In non-pregnant adults, the standard WHO/ADA protocol is used, with measurements while fasting and after one and two hours. In pregnant women, separate, lower diagnostic thresholds apply, and depending on the strategy adopted at a given facility, either a one-step protocol with 75 g of glucose (IADPSG) or a two-step protocol with 50 g of glucose as a screening test followed by 100 g of glucose with four measurements as a confirmatory test (Carpenter-Coustan) is used.
The OGTT remains the most sensitive single functional test available in routine diagnostics of carbohydrate metabolism disturbances, because it alone directly tests the body's ability to cope with a real glucose load, rather than merely assessing glucose concentration at rest or its averaged historical value. Its diagnostic value is especially great where other tests give a borderline or ambiguous result and a clinical decision requires precise resolution.
Mechanism of action
The physiological basis of the test is the observation that consuming a large, single dose of glucose triggers a coordinated response from the pancreas, liver, and peripheral tissues, whose efficiency directly reflects the state of the body's carbohydrate metabolism. The rise in glucose after drinking the glucose solution stimulates the pancreatic islet beta cells to rapidly secrete insulin, which in turn enhances glucose uptake by skeletal muscle and adipose tissue via the GLUT4 transporter and suppresses the liver's endogenous glucose production. In a healthy person, these mechanisms work efficiently enough that glucose returns to values close to baseline within two hours — the weaker the insulin response or the greater the tissue resistance to insulin, the longer glucose remains elevated.
Standardization of the test is key to its reliability — in non-pregnant adults, exactly 75 g of anhydrous glucose dissolved in 250–300 ml of water is used, drunk within a maximum of five minutes, with glucose measured while fasting and after one and two hours from drinking the solution. In pregnant women, the one-step protocol uses the identical 75 g dose measured at the same time points, but with lower diagnostic thresholds that account for the distinct, more stringent physiology of gestational glucose, while the two-step protocol uses a higher 100 g dose with an additional, fourth measurement after three hours.
The shape of the glucose curve, not a single point alone, carries significant diagnostic information. A normal response is characterized by a moderate rise in glucose in the first hour and a rapid return toward baseline in the second hour, reflecting efficient, early insulin secretion (the so-called first phase of secretion) and effective tissue glucose uptake. Impaired glucose tolerance manifests as persistently elevated glucose at the second hour despite normal or only slightly elevated fasting glucose, indicating a disturbance primarily in the early phase of insulin secretion or growing peripheral tissue insulin resistance. Overt diabetes is characterized by persistently elevated glucose both while fasting and at both subsequent measurement points.
It's worth emphasizing that the OGTT result alone — without an additional measurement of insulin or C-peptide at the same time points — doesn't allow one to definitively determine whether an abnormal glucose curve results primarily from insufficient insulin secretion by the pancreas or from peripheral tissue resistance to its action; both mechanisms produce a similar glycemic picture, and distinguishing between them requires an extended protocol with simultaneous insulinemia measurement, which makes such a modified OGTT a useful tool for assessing insulin resistance, complementing simpler indices based solely on fasting glucose and insulin.
Fasting glucose measurement
Blood drawn after 8–12 hours of fasting establishes the baseline value, the reference point for the rest of the curve.
Administration of a standard glucose dose
The patient drinks, within 5 minutes, a solution containing 75 g of anhydrous glucose, triggering the physiological insulin response.
Serial glucose measurements over time
Blood is drawn again after one and two hours, recording the pace and effectiveness of clearing glucose from the bloodstream.
Interpreting the curve against diagnostic thresholds
Values at each time point are compared against established thresholds for diagnosing normal, prediabetic, and diabetic states.
Evidence: strong — based on 2 studies in this database.
Benefits
Common myths
MythThe OGTT and HbA1c measure exactly the same thing.
FactHbA1c reflects average glucose over roughly the past three months, while the OGTT assesses the body's dynamic, current response to a specific glucose load — these are different, complementary parameters, not interchangeable ones.
MythFasting glucose alone is sufficient; the additional draws after the load are unnecessary.
FactIn many people it's precisely the glucose at hour 2 of the test, not the fasting value, that reveals impaired glucose tolerance, because the ability to clear a large glucose load deteriorates much earlier than baseline glucose does.
MythThe test result doesn't depend on what you eat before the test.
FactA low-carbohydrate diet in the days before the test can artificially worsen the result, which is why normal carbohydrate intake (at least about 150 g daily) is recommended for at least three days before the test.
MythThe OGTT can be performed at any point in pregnancy with the same significance.
FactThe standard screening window for gestational diabetes falls between weeks 24 and 28 of pregnancy, and performing the test outside this period changes the interpretation of the result and may require different reference thresholds.
Forms & variants
Oral Glucose Tolerance Test (OGTT) comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
75 g OGTT (WHO/ADA standard)
Measurement while fasting and after 1 and 2 hours from drinking 75 g of glucose.
Best for: Diagnosing diabetes and prediabetes in non-pregnant adults
75 g OGTT per IADPSG (pregnancy, one-step)
The same protocol as the standard, but with lower, pregnancy-specific diagnostic thresholds.
Best for: Screening for gestational diabetes at weeks 24–28 of pregnancy
100 g OGTT per Carpenter-Coustan (pregnancy, two-step)
A 50 g screening test, followed by a 100 g confirmatory test with four measurements.
Best for: Facilities using a two-step gestational diabetes screening strategy
OGTT extended with insulin
Additional measurement of insulinemia at the same time points as glucose.
Best for: Assessing insulin resistance and differentiating its causes in people with suspected metabolic syndrome
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
You should fast for 8–12 hours before the test and eat a normal diet containing at least 150 g of carbohydrates daily for at least three days before the test. During the test itself you must rest and not smoke.
HbA1c measures average glucose over roughly the past three months based on the degree of hemoglobin glycation, while the OGTT assesses the body's current, dynamic ability to metabolize a specific dose of glucose over time. Both tests provide complementary information.
In non-pregnant adults, normal glucose after 2 hours is below 140 mg/dl, values of 140–199 mg/dl indicate impaired glucose tolerance, and values of 200 mg/dl and above indicate diabetes. Separate, lower thresholds apply for pregnant women.
Yes, it's a routinely performed, safe screening test recommended for almost all pregnant women between weeks 24 and 28 of pregnancy, since undiagnosed gestational diabetes carries a significant risk of complications for both mother and child.
This is an intermediate state between normal and overt diabetes, in which glucose at the 2-hour mark of the test falls within the range of 140–199 mg/dl. People with such a result have a significantly elevated risk of developing type 2 diabetes in subsequent years and usually require lifestyle modification and periodic monitoring.
What to combine with
Good combinations
Type 2 Diabetes — The OGTT is one of three officially recognized tests for diagnosing diabetes, alongside fasting glucose and HbA1c
HbA1c (Glycated Hemoglobin) — HbA1c assesses average glucose over the past three months and complements the dynamic picture provided by the OGTT
Insulin Resistance — The OGTT extended with simultaneous insulinemia measurement is one of the tools used in assessing insulin resistance
Safety
Side effects & contraindications
Possible side effects
Nausea, dizziness, or a feeling of being unwell after drinking the concentrated glucose solution
Rarely, vomiting that prevents completing the test and requires repeating it on another day
Transient reactive hypoglycemia after the glucose peak in some people, manifesting as weakness and hand tremor
Discomfort from multiple venipunctures during the several-hour test
Contraindications
Previously diagnosed overt diabetes with significantly elevated fasting glucose — the test carries a risk of significant hyperglycemia without additional diagnostic value
Acute illness, fever, or infection on the day of the planned test, temporarily disrupting carbohydrate metabolism
Recent gastric surgery, including bariatric surgery, altering glucose absorption and potentially giving a falsely abnormal result
Severe pregnancy-related nausea or other intolerance preventing the full dose of the glucose solution from being drunk
Interactions
Medications affecting carbohydrate metabolism, such as glucocorticoids, certain diuretics, and beta-blockers, can distort the test result
A low-carbohydrate diet in the days before the test artificially inflates the result, mimicking a glucose intolerance that doesn't actually exist
Acute stress, infection, or several days of immobilization before the test raise glucose regardless of true glucose tolerance
Smoking during the test distorts the result and is prohibited throughout the entire test
Intense physical exertion immediately before or during the test alters muscle glucose uptake, disrupting interpretation of the curve
Endocrine disorders, such as hyperthyroidism or Cushing's syndrome, affect the result regardless of the underlying state of carbohydrate metabolism
Is it worth taking?
Who it's for
- People with borderline fasting glucose or an ambiguous HbA1c result requiring a more precise diagnosis
- Pregnant women as part of routine screening for gestational diabetes
- People with risk factors for type 2 diabetes (obesity, family history, polycystic ovary syndrome) despite normal fasting glucose
- Patients being diagnosed for insulin resistance or reactive postprandial hypoglycemia
Not for
- Previously diagnosed overt diabetes with significantly elevated fasting glucose — the test carries a risk of significant hyperglycemia without additional diagnostic value
- Acute illness, fever, or infection on the day of the planned test, temporarily disrupting carbohydrate metabolism
- Recent gastric surgery, including bariatric surgery, altering glucose absorption and potentially giving a falsely abnormal result
- Severe pregnancy-related nausea or other intolerance preventing the full dose of the glucose solution from being drunk
Evidence
Worth knowing
Diabetes is diagnosed on the OGTT at a glucose level ≥200 mg/dl (11.1 mmol/l) at the 120-minute mark, and prediabetes at a value of 140–199 mg/dl (7.8–11.0 mmol/l).
Glucose at the 2-hour mark of the test detects early disturbances in glucose tolerance more effectively than fasting glucose alone.
Pregnant women use lower diagnostic thresholds than non-pregnant people, because even mild gestational hyperglycemia carries a risk of obstetric complications.
The test can be extended with simultaneous insulin measurement, which allows distinguishing insulin resistance from insufficient insulin secretion by pancreatic beta cells.
Studies
Glucose assessed at the 120-minute mark of the oral glucose tolerance test detects early diabetes and impaired glucose tolerance more effectively than fasting glucose alone, making it a key diagnostic parameter of the test.
Bartoli E et al., European Journal of Internal Medicine, 2011
The oral glucose tolerance test (OGTT) revisited
Strong evidenceBartoli E, Fra GP, Carnevale Schianca GP · European Journal of Internal Medicine · 2011
A review of the history and contemporary significance of the oral glucose tolerance test, comparing its diagnostic value with fasting glucose alone in detecting early carbohydrate metabolism disturbances.
View study2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025
Strong evidenceAmerican Diabetes Association Professional Practice Committee · Diabetes Care · 2025
The annual American Diabetes Association guidelines defining current diagnostic criteria for diabetes and prediabetes, including thresholds based on the oral glucose tolerance test.
View studySources & bibliography
- Bartoli et al. 2011 — European Journal of Internal Medicine
- ADA 2025 — Diabetes Care, Standards of Care in Diabetes
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
210 publications on this site
Medical review
Michał NowakClinical Dietitian
Michał started out as a long-distance runner, before an injury forced him to rethink his career. Looking for a faster way back into shape, he discovered sports nutrition and never left — fascinated by the gap between the research and what "everyone knows" at the gym. He completed a degree in clinical dietetics, earned a sports-nutrition coaching certification, and ran his own practice for several years before joining VitMode. His writing keeps returning to one theme: a supplement won't replace the basics, but the right one, at the right time, makes a real difference — and that's the difference he tries to describe precisely, with citations instead of slogans. He still runs, though these days, as he puts it, purely for the fun of it.
130 publications on this site
Related entries
4.7Type 2 Diabetes
A chronic metabolic disease in which the body loses its ability to properly regulate blood glucose — and one of the few chronic diseases where a large randomized trial showed that lifestyle change alone can outperform a drug.
4.7HbA1c (Glycated Hemoglobin)
A biomarker reflecting average blood glucose over the past 2–3 months — the gold standard for diagnosing and monitoring diabetes, far more stable than a single glucose measurement.
4.6Insulin Resistance
A state in which the body's cells respond more weakly to insulin, forcing the pancreas to produce ever-larger amounts of it — the most common, and largely reversible, precursor of type 2 diabetes.
4.6Insulin
A key anabolic hormone regulating blood glucose levels — understanding how it works is the foundation of consciously managing metabolic health, regardless of whether someone has diabetes.
4.6Metabolic Syndrome
A cluster of five risk factors — from abdominal obesity to elevated triglycerides — that multiplies the risk of type 2 diabetes and cardiovascular disease, but is largely modifiable through lifestyle change.
4.8VO2 max
The maximum amount of oxygen the body can take up during exercise — one of the strongest, well-documented predictors of lifespan, measurable in a sports diagnostics lab.
4.7MRI (Magnetic Resonance Imaging)
MRI uses a strong magnetic field and radio waves, not ionizing radiation, to produce images with exceptionally high soft-tissue contrast — brain, spinal cord, joints, and internal organs — at the cost of a much longer scan time than CT.
4.7Mammography
An X-ray examination of the breast that is the primary method for screening detection of breast cancer at an early, asymptomatic stage — the only imaging test with mortality reduction documented in randomized clinical trials.
Related articles
PoradnikiTRT, Diabetes, and Insulin Resistance — Does Testosterone Affect Blood Sugar?
Low testosterone and insulin resistance go together far more often than chance would explain, and testosterone replacement therapy in men with hypogonadism and type 2 diabetes genuinely, though modestly, improves insulin sensitivity — but that's an addition to diabetes treatment, not a replacement for it.
August 15, 2026
PoradnikiPCOS and Diet: What to Eat, What to Avoid, to Actually Support Your Hormones
"Eat a low-glycemic-index diet" is the one line PCOS hears most often — rarely explained in terms of what it actually means on your plate. We break down the evidence for low-GI versus low-carb, show what actually moves insulin and androgens, and point out where diet ends and myth begins.
August 22, 2026
PoradnikiBerberine vs. Metformin: Does "Nature's Metformin" Really Measure Up?
"Nature's metformin" is one of the most repeated slogans in supplementation — and, surprisingly, one of the rare cases where a direct comparison with the drug actually exists. We check what that comparison really showed, how solid the 46-trial meta-analysis behind it is, and what popular headlines don't say about side effects.
August 22, 2026
PoradnikiWeekend Sleep Debt: Does Catching Up Actually Pay It Off?
"I sleep 5-6 hours on weeknights, but I catch up on weekends" is one of the most commonly repeated strategies for coping with sleep loss — intuitive, convenient, and, as a well-controlled laboratory study published in Current Biology shows, probably wrong. Weekend catch-up sleep not only failed to protect participants from the metabolic consequences of sleep loss, but on some measures worsened the drop in insulin sensitivity more than getting no catch-up sleep at all.
August 23, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.